Home » Topics » BioWorld Science

BioWorld Science
RSS

Extended funding supports Errium's development of therapeutics for chronic autoimmune diseases

July 1, 2022

CSF1R inhibition could delay muscular dystrophy progression

July 1, 2022

KLB as a novel druggable target for the prevention of NAFLD

July 1, 2022

Roche discovers new EGFR mutant inhibitors for NSCLC

July 1, 2022

Stingray Therapeutics synthesizes ENPP1 inhibitors

July 1, 2022

Tuojie Biotech identifies new P2X3 antagonists

July 1, 2022

Qurient Therapeutics discloses new CDK7 inhibitors

July 1, 2022

Albireo patents SLC10A1 and/or SLC10A2 inhibitors

July 1, 2022

Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure

July 1, 2022

CRV-431 is a possible treatment approach for ALD

July 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...